Indegene Limited (BOM:544172)
542.60
-9.35 (-1.69%)
At close: Aug 29, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
Enterprise Commercial Solutions | 15.87B | Log In | Log In | Log In | Log In | Upgrade |
Enterprise Commercial Solutions Growth | 3.82% | Log In | Log In | Log In | Log In | Upgrade |
Enterprise Medical Solutions | 8.03B | Log In | Log In | Log In | Log In | Upgrade |
Enterprise Medical Solutions Growth | 33.57% | Log In | Log In | Log In | Log In | Upgrade |
Omnichannel Activation | 3.48B | Log In | Log In | Log In | Log In | Upgrade |
Omnichannel Activation Growth | 8.96% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.02B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -27.66% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
United States | 19.74B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 15.47% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 7.61B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | -4.24% | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 675.00M | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Growth | 7.83% | Log In | Log In | Log In | Log In | Upgrade |
India | 194.00M | Log In | Log In | Log In | Log In | Upgrade |
India Growth | -13.00% | Log In | Log In | Log In | Log In | Upgrade |
North America | 178.00M | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 2125.00% | Log In | Log In | Log In | Log In | Upgrade |